1. Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma
   HIROKI NISHIKAWA et al, 2013, Oncology Reports CrossRef
2. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma
   HIROKI NISHIKAWA et al, 2014, Oncology Reports CrossRef
3. The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
   Hiroki Nishikawa et al, 2013, Gastroenterology Research and Practice CrossRef
4. Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers
   Yukio Osaki et al, 2013, Journal of Gastroenterology CrossRef
5. Clinical implication of the preoperative GSA index in 99mTc-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma
   HIROKI NISHIKAWA et al, 2015, Oncology Reports CrossRef
6. Radiofrequency ablation for hepatocellular carcinoma
   Hiroki Nishikawa et al, 2013, International Journal of Hyperthermia CrossRef
7. Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis
   Qing Pang, 2015, World Journal of Gastroenterology CrossRef
8. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma
   HIROKI NISHIKAWA et al, 2013, International Journal of Oncology CrossRef
9. Effect of nucleoside analog use in patients with hepatitis B virus‐related hepatocellular carcinoma
   Hiroki Nishikawa et al, 2014, Hepatology Research CrossRef
10. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria
    H Liu et al, 2016, British Journal of Surgery CrossRef
11. Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy
    Yunlong Zhang et al, 2022, Frontiers in Oncology CrossRef
12. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
    Xin Yin et al, 2014, BMC Cancer CrossRef
13. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma
    Atsushi Oyama et al, 2021, Hepatology Research CrossRef
14. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection
    HIROKI NISHIKAWA et al, 2015, Oncology Reports CrossRef
15. Clinical significance of therapy using branched‐chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma
    Hiroki Nishikawa et al, 2014, Hepatology Research CrossRef